Introduction
Recombinant Human SLC22A6 Protein, also known as solute carrier family 22 member 6, is a protein that plays a crucial role in the transport of organic cations across cell membranes. This protein is encoded by the SLC22A6 gene and is a member of the solute carrier family, which is a group of proteins that facilitate the transport of various molecules across cell membranes. Recombinant Human SLC22A6 Protein is widely used in scientific research and has various applications in the fields of pharmacology and toxicology.
Structure of Recombinant Human SLC22A6 Protein
Recombinant Human SLC22A6 Protein is a transmembrane protein that consists of 554 amino acids. It has a molecular weight of approximately 61.4 kDa and contains 12 transmembrane domains. The protein also has two large extracellular loops and two small intracellular loops. The N- and C- termini of the protein are located on the cytoplasmic side of the cell membrane.
The structure of Recombinant Human SLC22A6 Protein is highly conserved among different species, indicating its importance in cellular function. The protein has been extensively studied and its crystal structure has been determined, providing valuable insights into its function and mechanism of action.
Activity of Recombinant Human SLC22A6 Protein
Recombinant Human SLC22A6 Protein is a member of the organic cation transporter (OCT) family, which is responsible for the transport of organic cations across cell membranes. This protein specifically transports cationic drugs and endogenous compounds, such as neurotransmitters, hormones, and metabolites.
The activity of Recombinant Human SLC22A6 Protein is regulated by various factors, including pH, membrane potential, and other transporters. It functions as an antiporter, exchanging intracellular organic cations with extracellular ones. This activity is crucial for maintaining cellular homeostasis and plays a vital role in drug absorption, distribution, and elimination.
Applications of Recombinant Human SLC22A6 Protein
Recombinant Human SLC22A6 Protein has various applications in the fields of pharmacology and toxicology. Its role in drug transport and metabolism makes it a valuable tool for studying drug-drug interactions and drug toxicity. The protein is also involved in the transport of endogenous compounds, making it a potential target for drug development.
In pharmacology, Recombinant Human SLC22A6 Protein is used to study the transport and pharmacokinetics of cationic drugs. Its expression in different tissues and organs also allows for the investigation of tissue-specific drug distribution. This information is crucial for optimizing drug dosing and reducing adverse effects.
In toxicology, Recombinant Human SLC22A6 Protein is used to study the transport and elimination of toxic compounds. Its activity can be modulated by various factors, such as drug interactions and genetic polymorphisms, which can affect the toxicity of certain drugs.
Conclusion
In conclusion, Recombinant Human SLC22A6 Protein is a transmembrane protein that plays a critical role in the transport of organic cations across cell membranes. Its structure, activity, and applications have been extensively studied and provide valuable insights into its function and mechanism of action. This protein is a valuable tool for studying drug transport and metabolism and has various applications in pharmacology and toxicology. Further research on this protein may lead to the development of new drugs and therapies for various diseases.
There are no reviews yet.